Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, California
- Most recent report
- 10-Q, filed Aug 6, 2026
- Incorporated
- Delaware
- Filings on record
- 440 filings
- On EDGAR
- CIK 1817713
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 21
News 8 of 49
Prospectuses and Registrations 8 of 19
- S-8 Registration statement for an employee plan Feb 26, 2026
- S-8 Registration statement for an employee plan Feb 27, 2025
- 424B5 Prospectus supplement for an offering Dec 5, 2024
- 424B5 Prospectus supplement for an offering Dec 3, 2024
- S-3ASR Automatic shelf registration May 8, 2024
- S-8 Registration statement for an employee plan Mar 8, 2024
- 424B5 Prospectus supplement for an offering Feb 29, 2024
- FWP Free writing prospectus Feb 29, 2024
Proxies 8 of 11
- DEFA14A Extra proxy material Apr 28, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2026
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEFA14A Extra proxy material Jun 17, 2024
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- DEFA14A Extra proxy material Apr 28, 2023
Ownership 8 of 316
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 13, 2026
- 4 Insider reported a trade Jul 31, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Jul 28, 2026
- 4 Insider reported a trade Jul 10, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
- 4 Insider reported a trade Jun 12, 2026
Other 8 of 24
- ARS Annual report sent to shareholders Apr 28, 2026
- ARS Annual report sent to shareholders Apr 25, 2025
- ARS Annual report sent to shareholders Apr 29, 2024
- ARS Annual report sent to shareholders Apr 28, 2023
- EFFECT Notice that a registration became effective Sep 19, 2022
- CORRESP Reply to SEC staff Sep 15, 2022
- UPLOAD Comment letter from SEC staff Aug 11, 2022
- EFFECT Notice that a registration became effective Jun 10, 2021
Everything here comes from Janux Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.